Officials said that the she was transferred in a highly precautionary process.
Advertisement
This morning Pauline Cafferkey, the nurse who survived infection with the Ebola virus, was airlifted to an isolation unit at the Royal Free Hospital in London after the Ebola virus was detected in blood samples.
Thus, as of writing, the risk resulting from the incident remains fairly low.
“She will be in our prayers and our thoughts now”.
The 39-year-old was taken to the hospital, run by NHS Greater Glasgow and Clyde, after feeling unwell and was treated in its infectious diseases unit.
Ms Cafferkey was in a critical condition while in isolation at the hospital before making a full recovery.
Colleagues who worked with her have spoken of Ms Cafferkey’s dedication and enthusiasm for her role at the Ebola Treatment Centre in Kerry Town.
Her temperature was tested seven times at Heathrow airport and she was deemed fit to travel before taking ill.
She was kept in an isolation unit at the Royal Free for nearly a month at the beginning of this year.
She met the Prime Minister’s wife Samantha Cameron the following day at Downing Street, alongside other winners.
“Pauline’s condition is a complication of a previous infection with the Ebola virus”, Dr Crighton said.
The news came just two days after the World Health Organization announced that the three West African countries at the heart of the epidemic had their first Ebola-free week since March 2014.
Virologist Dr Ben Neuman told the broadcaster: “The nice news here is that she’s beaten the virus once, so she can probably beat it again”.
Ebola can easily be transmitted through close contact or direct contact with blood and exchange of bodily fluids.
Cafferkey was flown to London early Friday from Scotland, where she lives. She was in good health and excited to be here.
It is not clear what symptoms the nurse is exhibiting, but the police closed all roads so that the ambulance could rush her “to the nearby hospital in Hampstead”.
Advertisement
J&J, which is working with Bavarian Nordic in developing its vaccine, said on Friday that trial recruitment was underway and the first volunteers had received their initial vaccine dose.
